Late Edition July 21 2008 at 03:22 PM Edited by Chi-Chu Tschang and Harry Maurer
Peace at Yahoo?
Billionaire investor Carl Icahn ended his crusade to toss out the Yahoo! board by agreeing to take a seat on the board along with two others from his slate. The agreement represents a major retreat by Icahn, who may have been influenced by the news last week that Yahoo's biggest shareholder would vote his shares against Icahn.
Icahn originally hoped to push through a sale of Yahoo to Microsoft, but the software giant says it's no longer interested. Nevertheless, he'll probably keep lobbying for a deal, and failing that, will probably push Yahoo to take other actions to bolster the stock price.
Source: BusinessWeek
Bank of America Beats Expectations
The big bank became the latest to report a big profit drop that nevertheless pleased Wall Street. Second-quarter net income fell 41%, to 72 cents a share, but that far surpassed analysts' average forecast of 54 cents. The stock was up nearly 4% in midafternoon trading and has now gained 60% in a week.
Source: Bloomberg
A New Departure at Citi
Citigroup's Michael Klein, who was regarded as the chief rival to Vikram Pandit when Pandit was named CEO upon the resignation of Charles Prince, is leaving the bank to "pursue other opportunities." Klein, a 23-year veteran at the bank, has been head of the institutional clients group since March.
Source: Wall Street Journal
Schering-Plough and Merck Take a Hit
Shares of both pharmaceutical companies sagged after a study on their jointly marketed anti-cholesterol drug, Vytorin, showed disappointing results. Vytorin is a combination of the drugs Zetia and simvastatin, which use different mechanisms to reduce levels of bad cholesterol. Both Vytorin and stand-alone Zetia are marketed by a joint venture of Merck and Schering-Plough; and had combined sales of more than $5 billion in 2007. The study failed to show any benefit for patients with a heart-valve problem, which was its primary goal. In midafternoon trading, Schering was down more than 13% and Merck more than 6%.
Source: CNNMoney.com
Trade Talks Begin
Trade officials from the world's leading economies gathered in Geneva on July 21 for a make-or-break session of world trade talks. After nearly seven years of fruitless haggling, ministers will try to bridge gaps on trade-opening measures under the Doha Development Agenda, which was launched in the Qatari capital in 2001. The goals of the discussions are to cut farm subsidies and tariffs, as well as to help developing countries prosper through trade. The talks also cover manufactured goods and services -- areas in which rich countries like the U.S. and the members of the European Union hope to make gains in order to sell politically painful farm trade reforms at home.
Source: Financial Times, Agence France-Presse
HSBC courts Chinese investment
HSBC Holdings, Europe's largest bank, has reportedly held talks with the China Investment Corporation (CIC) in a bid to attract investment from the Chinese sovereign wealth fund. According to Britain's Sunday Telegraph newspaper, HSBC Chairman Stephen Green met officials from CIC several times in recent months for discussions that included the possibility of CIC buying HSBC shares in the open market. An HSBC spokesperson said the bank doesn't comment on specific meetings.
Source: Bloomberg
Roche offers $43.7 to buy Genentech
Swiss drugmaker Roche on July 21 offered to buy all outstanding shares in its U.S. partner Genentech for $43.7 billion in cash to reinforce its position in cancer medicines. Roche, which already owns 55.9% of Genentech, said it would offer $89 per share to acquire the remaining stake, a 9% premium to the biotech company's closing share price on July 18. Basel-based Roche also announced first-half net profits of $5.62 billion, a 2% drop from the same period last year.
Source: Reuters
Credit crunch enters second year
With the credit crunch on Wall Street entering its second year, a widening array of businesses are finding it tough to get credit. That's combined with the fallout from mortgage giants Fannie Mae and Freddie Mac, which has made it harder for individuals to get a loan.
Source: Wall Street Journal
U.S. consumers face soaring food prices
U.S. food companies are preparing another round of price increases as rising commodity costs force them to pass the increases on to consumers. According to the U.S. Department of Labor, domestic food prices have jumped 5.3% for the year ending in June, adding to the pressures on Americans from rising unemployment, a slumping housing market, and higher gas prices. Food prices rose 0.8% in June compared to 0.3% in May.
Source: Financial Times
U.S. looks to cash in on India's nuclear industry
For the past three years, executives from U.S.-based producers of nuclear power plants have been making a beeline for New Delhi. Under an agreement between the two countries, India -- which has been subject to sanctions since testing a nuclear weapon 10 years ago -- will be able to buy and sell nuclear technology in the international marketplace in exchange for opening its civilian reactors to inspections.
Source: BusinessWeek
Fall-out from Fannie Mae, Freddie Mac hits foreign investors
About one-fifth of securities issued by Fannie Mae, Freddie Mac, and a handful of much smaller quasi-governmental organizations -- valued around $1.5 trillion -- are held by foreign investors. Now that the two companies are at risk, how their rescue is handled will ultimately test the world's faith in American markets. Analysts reckon it also could influence the level of interest rates and weigh on the strength of the dollar for years to come.
Source: New York Times
Batman breaks box office record
According to early estimates, the new Batman movie sold $155.3 million tickets between July 18 and July 20, setting a record for the biggest three-day take ever for a Hollywood movie.
Source: Los Angeles Times
Conversation of the Day: The Alternative Energy Puzzle
Reader Charles Cresson Wood Writes: "Many alternative fuels are now cost competitive with gasoline and petro-diesel. Beyond ethanol and hydrogen, organizations should be looking into other commercially available fuels."
| This newsletter is a FREE service provided by BusinessWeek. To sign up for other newsletters, cancel delivery, change delivery options or change your e-mail address, please go to our Newsletter Preferences page. If you need other assistance, please contact Customer Service or contact: Wanda Cooper BusinessWeek Customer Rights Communications Data Services 1995 G Avenue Red Oak, IA 51566 Phone: 1-800-635-1200 View our corporate privacy policy at http://www.mcgraw-hill.com/privacy.html. To learn more about how BusinessWeek applies this policy, you can contact our Marketing Department . Copyright 2007, by The McGraw-Hill Companies Inc. All rights reserved. Terms of Use | Privacy Notice |
No comments:
Post a Comment
Keep a civil tongue.